The enhancement of BBB permeability by endothelial IRS-1 overexpression, however, suggests endothelial IRS-1 as a good candidate for augmenting therapeutic drug delivery across the BBB for the treatment of brain disorders, such as brain tumor or neurodegenerative diseases. The gene discussed is IRS1; the disease is brain neoplasm.